A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
<h4>Background</h4>A DNA-prime/human adenovirus serotype 5 (HuAd5) boost vaccine encoding Plasmodium falciparum (Pf) circumsporozoite protein (PfCSP) and Pf apical membrane antigen-1 (PfAMA1), elicited protection in 4/15 (27%) of subjects against controlled human malaria infection (CHMI)...
Guardado en:
Ejemplares similares
-
Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria
por: Flora Satiko Kano, et al.
Publicado: (2018) -
Antigen Export during Liver Infection of the Malaria Parasite Augments Protective Immunity
por: Georgina N. Montagna, et al.
Publicado: (2014) -
Considerations for quality assurance of multiplex malaria antigen detection assays with large sample sets
por: Rachel Alvarado, et al.
Publicado: (2021) -
Antigenic variation in Plasmodium falciparum malaria involves a highly structured switching pattern.
por: Mario Recker, et al.
Publicado: (2011) -
Impact of IgG response to malaria-specific antigens and immunity against malaria in pre-school children in Ghana. A cluster randomized, placebo-controlled trial.
por: Samuel Kofi Tchum, et al.
Publicado: (2021)